Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer

Oncogene

Volumn 21, Issue 39, 2002, Pages 6059-6070

  Koliopanos, Alexander ^b   Kleeff, Jörg ^a,b   Xiao, Yi ^a,b   Safe, Stephen ^d   Zimmermann, Arthur ^c   Büchler, Markus W ^a,b   Friess, Helmut ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Arylhydrocarbon receptor; Cell cycle; Chemotherapy; Cytochrome P450; Pancreatic cancer

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ARYLHYDROCARBON RECEPTOR; CELL RECEPTOR; CYCLIN DEPENDENT KINASE; CYTOCHROME P450 1A1; MESSENGER RNA; PROTEIN P21; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; BLOTTING, NORTHERN; CELL ADHESION; CHRONIC DISEASE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTOCHROME P-450 CYP1A1; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TUMOR CELLS, CULTURED;

EID: 0037026632     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205633     Document Type: Article

References (89)

1. Abe M, Yamashita J and Ogawa M. (2000). Cancer, 88, 2000-2009.
2. Andren-Sandberg A, Hoem D and Backman PL. (1999). Ann. Oncol., 10, 131-135.
3. Angus WG, Larsen MC and Jefcoate CR. (1999). Carcinogenesis, 20, 947-955.
4. Astroff B and Safe S. (1989). Toxicology, 59, 285-296.
5. Becher H, Flesch-Janys D, Kauppinen T, Kogevinas M, Steindorf K, Manz A and Wahrendorf J. (1996). Cancer Causes Control, 7, 312-321.
6. Bertazzi PA, Consonni D, Bachetti S, Rubagotti M, Baccarelli A, Zocchetti C and Pesatori AC. (2001). Am. J. Epidemiol., 153, 1031-1044.
7. Bertazzi PA, Zocchetti C, Guercilena S, Consonni D, Trioni A, Landi MT and Pesatori AC. (1997). Epidemiology, 8, 646-652.
8. Büchler M, Friess H, Schultheiss KH, Gebhardt C, Kubel R, Muhrer KH, Winkelmann M, Wagener T, Klapdor R, Kaul M, Muller G, Schulz G and Beger HG. (1991). Cancer, 68, 1507-1512.
9. Buckingham J and Macdonald F. (1997). Dictionary of Organic Compounds. Sixth edn. New York: Chapman and Hall Electronic Publishing Division.
10. Carver LA, Hogenesch JB and Bradfield CA, (1994). Nucleic Acids Res., 22, 3038-3044.
11. Chen I, McDougal A, Wang F and Safe S. (1998). Carcinogenesis, 19, 1631-1639.
12. Cheung YL, Kerr AC, McFadyen MC, Melvin WT and Murray GI. (1999). Cancer Lett., 139, 199-205.
13. Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim CS, Bjeldanes LF and Firestone GL. (1998). J. Biol. Chem., 273, 3838-3847.
14. Denison MS, Fisher JM and Whitlock Jr JP. (1988). J. Biol. Chem., 263, 17221-17224.
15. Dolwick KM, Schmidt JV, Carver LA, Swanson HI and Bradfield CA. (1993). Mol. Pharmacol., 44, 911-917.
16. Dreisbach RH and Robertson WO. (1987). Handbook of Poisoning: prevention, diagnosis and treatment. 12th edn. Norwalk, Conn, USA: Appleton & Lange.
17. Elferink CJ, Gasiewicz TA and Whitlock Jr JP. (1990). J. Biol. Chem., 265, 20708-20712.
18. Fernandez-Salguero PM, Hilbert DM, RudikoffS, Ward JM and Gonzalez FJ. (1996). Toxicol. Appl. Pharmacol., 140, 173-179.
19. Fingerhut MA, Halperin WE, Marlow DA, Piacitelli LA, Honchar PA, Sweeney MH, Greif AL, Dill PA, Steenland K and Suruda AJ. (1991). N. Engl. J. Med., 324, 212-218.
20. Friess H, Buchler M, Kruger M and Beger HG. (1992). Pancreas, 7, 516-521.
21. Friess H, Yamanaka Y, Buchler M, Berger HG, Kobrin MS, Baldwin RL and Korc M. (1993). Cancer Res., 53, 2704-2707.
22. Geiger LE and Neal RA. (1981). Toxicol. Appl. Pharmacol., 59, 125-129.
23. Goodman LS, Gilman A and Gilman AG. (1990). Goodman and Gilman's: The Pharmacological Basis of Therapeutics 8th edn. New York: Pergamon Press.
24. Hankinson O. (1995). Annu. Rev. Pharmacol. Toxicol., 35, 307-340.
25. Harris M, Zacharewski T, Astroff B and Safe S. (1989). Mol. Pharmacol., 35, 729-735.
26. Hayashi S, Watanabe J, Nakachi K, Eguchi H, Gotoh O and Kawajiri K. (1994). Carcinogenesis, 15, 801-806.
27. Hayes WJ (1982).). Pesticides Studied in Man. Baltimore: Williams and Wilkins.
28. Hoffman EC, Reyes H, Chu FF, Sander F, Conley LH, Brooks BA and Hankinson O. (1991). Science, 252, 954-958.
29. Huff J, Lucier G and Tritscher A. (1994). Annu. Rev. Pharmacol. Toxicol., 34, 343-372.
30. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. (1987). Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. This publication represents the views and expert opinions of an IARC ad-hoc Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 10-18 March 1987. Lyon, France and Geneva, Switzerland: World Health Organization International Agency for Research on Cancer; Distributed by the World Health Organization Distribution and Sales Service.
31. International Agency for Research on Cancer and World Health Organization. (1987). Overall evaluations of carcinogenecity: an updating of lARC monographs, volumes 1-42. Lyon, France: International Agency for Research on Cancer.
32. Jana NR, Sarkar S, Ishizuka M, Yonemoto J, Tohyama C and Sone H. (1999). Biochem. Biophys. Res. Comm., 256, 462-468.
33. Johnson ES. (1991). Crit. Rev. Toxicol., 21, 451-463.
34. Jones PB, Durrin LK, Fisher JM and Whitlock Jr JP. (1986). J. Biol. Chem., 261, 6647-6650.
35. Kashani M, Steiner G, Haitei A, Schaufter K, Thalhammer T, Amann G, Kramer G, Marberger M and Scholler A. (1998). Prostate, 37, 98-108.
36. Kobayashi A, Sogawa K and Fujii-Kuriyama Y. (1996). J. Biol. Chem., 271, 12310-12316.
37. Kojima T, Tanaka T and Mori H. (1994). Cancer Res., 54, 1446-1449.
38. Kolluri SK, Weiss C, Koff A and Gottlicher M. (1999). Genes Dev., 13, 1742-1753.
39. Krishnan V, Porter W, Santostefano M, Wang X and Safe S. (1995). Mol. Cell. Biol., 15, 6710-6719.
40. Krishnan V, Wang X and Safe S. (1994). J. Biol. Chem., 269, 15912-15917.
41. Kuil CW, Brouwer A, van der Saag PT and van der Burg B. (1998). J. Biol. Chem., 273, 8829-8834.
42. Landers JP and Bunce NJ. (1991). Biochem. J., 276, 273-287.
43. Ledirac N, Delescluse C, Lesca P, Piechocki MP, Hines RN, de Sousa G, Pralavorio M and Rahmani R. (2000). Toxicol. Appl. Pharmacol., 164, 273-279.
44. Li W, Harper PA, Tang BK and Okey AB. (1998). Biochem. Pharmacol., 56, 599-612.
45. Ma Q and Whitlock Jr JP. (1996). Mol. Cell. Biol., 16, 2144-2150.
46. Matsushita N, Sogawa K, Ema M, Yoshida A and Fujii-Kuriyama Y. (1993). J. Biol. Chem., 268, 21002-21006.
47. McDougal A, Gupta MS, Morrow D, Ramamoorthy K, Lee JE and Safe SH. (2001). Breast Cancer Res. Treat., 66, 147-157.
48. McDougal A, Wilson C and Safe S. (1997). Cancer Lett., 120, 53-63.
49. Morse MA, LaGreca SD, Amin SG and Chung FL. (1990). Cancer Res., 50, 2613-2617.
50. Norman J, Franz M, Schiro R, Nicosia S, Docs J, Fabri PJ and Gower Jr WR. (1994). J. Surg. Res., 57, 33-38.
51. Oikawa K, Ohbayashi T, Mimura J, Iwata R, Kameta A, Evine K, Iwaya K, Fujii-Kuriyama Y, Kuroda M and Mukai K. (2001). Cancer Res., 61, 5707-5709.
52. Parker SL, Tong T, Bolden S and Wingo PA. (1997). CA Cancer J. Clin., 47, 5-27.
53. Patikoglou G and Burley SK. (1997). Annu. Rev. Biophys. Biomol. Struct., 26, 289-325.
54. Poland A and Glover E. (1979). Cancer Res., 39, 3341-3344.
55. Poland A and Knutson JC. (1982). Annu. Rev. Pharmacol. Toxicol., 22, 517-554.
56. Poland AP, Glover E, Robinson JR and Nebert DW. (1974). J. Biol. Chem., 249, 5599-5606.
57. Quattrochi LC, Vu T and Tukey RH. (1994). J. Biol. Chem., 269, 6949-6954.
58. Ramamoorthy K, Gupta MS, Sun G, McDougal A and Safe SH. (1999). Carcinogenesis, 20, 115-123.
59. Reyes H, Reisz-Porszasz S and Hankinson O. (1992). Science, 256, 1193-1195.
60. Rininger JA, Stroffregen DA and Babish JG. (1997). Chemosphere, 34, 1557-1568.
61. Rowlands C, Krishnan V, Wang X, Santostefano M, Safe S, Miller WR and Langdon S. (1993). Cancer Res., 53, 1802-1807.
62. Roy NK and Wirgin I. (1997). Arch. Biochem. Biophys., 344, 373-386.
63. Safe S. (2001). Toxicol. Lett., 120, 1-7.
64. Safe S, Wang F, Porter W, Duan R and McDougal A. (1998). Toxicol. Lett., 102, 103, 343-347.
65. Sakai DD, Helms S, Carlstedt-Duke J, Gustafsson JA, Rottman FM and Yamamoto KR. (1988). Genes Dev., 2, 1144-1154.
66. Sax NI and Lewis RJ. (1989). Dangerous Properties of Industrial Materials. 7th edn. New York: Van Nostrand Reinhold,.
67. Sittig M. (1985). Handbook of Toxic and Hazardous Chemicals and Carcinogens, 2nd edn. Park Ridge, NJ, USA: Noyes Publications,.
68. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR. (1990). J. Natl. Cancer Inst., 82, 1107-1112.
69. Skene SA, Dewhurst IC and Greenberg M. (1989). Hum. Toxicol., 8, 173-203.
70. Spink BC, Fasco MJ, Gierthy JF and Spink DC. (1998). J. Cell Biochem., 70, 289-296.
71. Steenland K, Piacitelli L, Deddens J, Fingerhut M and Chang LI. (1999). J. Natl. Cancer Inst., 91, 779-786.
72. Stoewsand GS, Anderson JL and Munson L. (1988). Cancer Lett., 39, 199-207.
73. Strahle U, Schmid W and Schutz G. (1988). EMBO J., 7, 3389-3395.
74. Sun G and Safe S. (1997). Cancer Chemother. Pharmacol., 40, 239-244.
75. Sutter TR, Guzman K, Dold KM and Greenlee WF. (1991). Science, 254, 415-418.
76. Swanson HI and Bradfield CA. (1993). Pharmacogenetics, 3, 213-230.
77. Takahashi Y, Nakayama K, Shimojima T, Itoh S and Kamataki T. (1996). Eur. J. Biochem., 242, 512-518.
78. Takeuchi Y, Nakao A, Harada A, Nonami T, Fukatsu T and Takagi H. (1993), Am. J. Gastroenterol., 88, 1928-1933.
79. Vang O, Jensen MB and Autrup H. (1990). Carcinogenesis, 11, 1259-1263.
80. Vickers PJ, Dufresne MJ and Cowan KH. (1989). Mol. Endocrinol., 3, 157-164.
81. Wang F, Wang W and Safe S. (1999). Biochemistry, 38, 11490-11500.
82. Wang X, Rosengren R, Morrison V, Santostefano M and Safe S. (1992). Biochem. Pharmacol., 43, 1635-1642.
83. Wang X, Thomsen JS, Santostefano M, Rosengren R, Safe S and Perdew GH. (1995). Eur. J. Pharmacol., 293, 191-205.
84. Wattenberg LW and Loub WD. (1978). Cancer Res., 38, 1410-1413.
85. Weiss C, Kolluris K, Kiefer F and Gottlicher M. (1996). Exp. Cell Res., 226, 154-163.
86. Windholz M, Budavari S, Blumetti RF and Otterbein ES. (1983). The Merck Index: an encyclopedia of Chemicals, Drugs and Biologicals, 10th edn. Rahway, NJ, USA: Merck.
87. Wormke M, Castro-Rivera E, Chen I and Safe S. (2000). J. Steroid Biochem. Mol. Biol., 72, 197-207.
88. Wu L and Whitlock Jr JP. (1992). Proc. Natl. Acad. Sci. USA, 89, 4811-4815.
89. Zacharewski TR, Bondy KL, McDonell P and Wu ZF. (1994). Cancer Res., 54, 2707-2713.